Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics.

Coups EJ, Manne SL, Ohman Strickland P, Hilgart M, Goydos JS, Heckman CJ, Chamorro P, Rao BK, Davis M, Smith FO, Thorndike FP, Ritterband LM.

Contemp Clin Trials. 2019 Aug;83:117-127. doi: 10.1016/j.cct.2019.06.014. Epub 2019 Jun 27.

PMID:
31255801
2.

Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo.

Shin SS, Jeong BS, Wall BA, Li J, Shan NL, Wen Y, Goydos JS, Chen S.

Oncogenesis. 2018 Nov 14;7(11):86. doi: 10.1038/s41389-018-0098-7.

3.

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.

Mehnert JM, Silk AW, Lee JH, Dudek L, Jeong BS, Li J, Schenkel JM, Sadimin E, Kane M, Lin H, Shih WJ, Zloza A, Chen S, Goydos JS.

Pigment Cell Melanoma Res. 2018 Jul;31(4):534-540. doi: 10.1111/pcmr.12694. Epub 2018 Apr 10.

4.

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness.

Isola AL, Eddy K, Zembrzuski K, Goydos JS, Chen S.

Oncotarget. 2017 Dec 19;9(1):1187-1199. doi: 10.18632/oncotarget.23455. eCollection 2018 Jan 2.

5.

Parent and Child Characteristics Associated with Child Sunburn and Sun Protection Among U.S. Hispanics.

Day AK, Stapleton JL, Natale-Pereira AM, Goydos JS, Coups EJ.

Pediatr Dermatol. 2017 May;34(3):315-321. doi: 10.1111/pde.13136.

PMID:
28523887
6.

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma.

Boregowda RK, Medina DJ, Markert E, Bryan MA, Chen W, Chen S, Rabkin A, Vido MJ, Gunderson SI, Chekmareva M, Foran DJ, Lasfar A, Goydos JS, Cohen-Solal KA.

Oncotarget. 2016 May 17;7(20):29689-707. doi: 10.18632/oncotarget.8822.

7.

Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.

McMasters KM, Egger ME, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, Martin RC 2nd, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Davidson BS, Gershenwald JE, Hagendoorn LJ, Stromberg AJ, Scoggins CR.

J Clin Oncol. 2016 Apr 1;34(10):1079-86. doi: 10.1200/JCO.2015.63.3776. Epub 2016 Feb 8.

8.

Acral Lentiginous Melanoma.

Goydos JS, Shoen SL.

Cancer Treat Res. 2016;167:321-9. doi: 10.1007/978-3-319-22539-5_14. Review.

PMID:
26601870
9.

Occupational sunscreen use among US Hispanic outdoor workers.

Day AK, Stapleton JL, Natale-Pereira AM, Goydos JS, Coups EJ.

BMC Res Notes. 2015 Oct 17;8:578. doi: 10.1186/s13104-015-1558-1.

10.

Receptivity to Internet-Delivered Interventions to Promote Skin Self-examination and Sun Protection Behaviors in Patients With Melanoma.

Day AK, Stapleton JL, Manne SL, Tatum KL, Goydos JS, Coups EJ.

JAMA Dermatol. 2016 Feb;152(2):213-5. doi: 10.1001/jamadermatol.2015.2978. No abstract available.

PMID:
26465805
11.

Skin self-examination behaviors among individuals diagnosed with melanoma.

Coups EJ, Manne SL, Stapleton JL, Tatum KL, Goydos JS.

Melanoma Res. 2016 Feb;26(1):71-6. doi: 10.1097/CMR.0000000000000204.

PMID:
26426762
12.

Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression.

Rosenberg SA, Niglio SA, Salehomoum N, Chan JL, Jeong BS, Wen Y, Li J, Fukui J, Chen S, Shin SS, Goydos JS.

Transl Oncol. 2015 Feb;8(1):1-9. doi: 10.1016/j.tranon.2014.11.001.

13.

Interdigitating dendritic cell sarcoma presenting in the skin: diagnosis and the role of surgical resection, chemotherapy and radiotherapy in management.

Rosenberg SA, Niglio SA, Jo VY, Goydos JS.

Rare Tumors. 2014 Dec 11;6(4):5573. doi: 10.4081/rt.2014.5573. eCollection 2014 Oct 27.

14.

Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells.

Wall BA, Yu LJ, Khan A, Haffty B, Goydos JS, Chen S.

Pigment Cell Melanoma Res. 2015 Jan;28(1):105-9. doi: 10.1111/pcmr.12327. Epub 2014 Nov 28.

15.

Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling.

Baljinnyam E, Umemura M, Chuang C, De Lorenzo MS, Iwatsubo M, Chen S, Goydos JS, Ishikawa Y, Whitelock JM, Iwatsubo K.

Pigment Cell Melanoma Res. 2014 Jul;27(4):611-20. doi: 10.1111/pcmr.12250. Epub 2014 May 9.

16.

RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.

Boregowda RK, Olabisi OO, Abushahba W, Jeong BS, Haenssen KK, Chen W, Chekmareva M, Lasfar A, Foran DJ, Goydos JS, Cohen-Solal KA.

Cancer Lett. 2014 Jun 28;348(1-2):61-70. doi: 10.1016/j.canlet.2014.03.011. Epub 2014 Mar 18.

17.

Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration.

Umemura M, Baljinnyam E, Feske S, De Lorenzo MS, Xie LH, Feng X, Oda K, Makino A, Fujita T, Yokoyama U, Iwatsubo M, Chen S, Goydos JS, Ishikawa Y, Iwatsubo K.

PLoS One. 2014 Feb 21;9(2):e89292. doi: 10.1371/journal.pone.0089292. eCollection 2014.

18.

Psychosocial correlates of sun protection behaviors among U.S. Hispanic adults.

Coups EJ, Stapleton JL, Manne SL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon M, Tatum KS, Robinson JK, Natale-Pereira A, Goydos JS.

J Behav Med. 2014 Dec;37(6):1082-90. doi: 10.1007/s10865-014-9558-5. Epub 2014 Feb 15.

19.

Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.

Wen Y, Li J, Koo J, Shin SS, Lin Y, Jeong BS, Mehnert JM, Chen S, Cohen-Sola KA, Goydos JS.

Cancer Res. 2014 May 1;74(9):2499-509. doi: 10.1158/0008-5472.CAN-13-1531. Epub 2014 Feb 3.

20.

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH.

PLoS One. 2014 Jan 3;9(1):e81126. doi: 10.1371/journal.pone.0081126. eCollection 2014.

21.

Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.

Wall BA, Wangari-Talbot J, Shin SS, Schiff D, Sierra J, Yu LJ, Khan A, Haffty B, Goydos JS, Chen S.

Pigment Cell Melanoma Res. 2014 Mar;27(2):263-74. doi: 10.1111/pcmr.12207. Epub 2014 Jan 22.

22.

Who should be offered a sentinel node biopsy for melanoma less than 1 mm in thickness?

Goydos JS.

J Clin Oncol. 2013 Dec 10;31(35):4385-6. doi: 10.1200/JCO.2013.51.8423. Epub 2013 Nov 4. No abstract available.

PMID:
24190121
23.

Linguistic acculturation and skin cancer-related behaviors among Hispanics in the southern and western United States.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon MA, Natale-Pereira A, Goydos JS.

JAMA Dermatol. 2013 Jun;149(6):679-86. doi: 10.1001/jamadermatol.2013.745.

24.

Skin cancer surveillance behaviors among US Hispanic adults.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon M, Natale-Pereira A, Goydos JS.

J Am Acad Dermatol. 2013 Apr;68(4):576-584. doi: 10.1016/j.jaad.2012.09.032. Epub 2012 Nov 19.

25.

Sun protection and exposure behaviors among Hispanic adults in the United States: differences according to acculturation and among Hispanic subgroups.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Natale-Pereira A, Goydos JS.

BMC Public Health. 2012 Nov 15;12:985. doi: 10.1186/1471-2458-12-985.

26.

Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma.

Abushahba W, Olabisi OO, Jeong BS, Boregowda RK, Wen Y, Liu F, Goydos JS, Lasfar A, Cohen-Solal KA.

PLoS One. 2012;7(10):e47312. doi: 10.1371/journal.pone.0047312. Epub 2012 Oct 12.

27.

Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.

Ochoa-Alvarez JA, Krishnan H, Shen Y, Acharya NK, Han M, McNulty DE, Hasegawa H, Hyodo T, Senga T, Geng JG, Kosciuk M, Shin SS, Goydos JS, Temiakov D, Nagele RG, Goldberg GS.

PLoS One. 2012;7(7):e41845. doi: 10.1371/journal.pone.0041845. Epub 2012 Jul 23.

28.

Skin cancer screening among Hispanic adults in the United States: results from the 2010 National Health Interview Survey.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Goydos JS, Natale-Pereira A.

Arch Dermatol. 2012 Jul;148(7):861-3. doi: 10.1001/archdermatol.2012.615. No abstract available.

29.

Functional effects of GRM1 suppression in human melanoma cells.

Wangari-Talbot J, Wall BA, Goydos JS, Chen S.

Mol Cancer Res. 2012 Nov;10(11):1440-50. doi: 10.1158/1541-7786.MCR-12-0158. Epub 2012 Jul 13.

30.

Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.

Lee HJ, Wall BA, Wangari-Talbot J, Shin SS, Rosenberg S, Chan JL, Namkoong J, Goydos JS, Chen S.

Clin Cancer Res. 2011 Nov 15;17(22):7080-92. doi: 10.1158/1078-0432.CCR-11-0098. Epub 2011 Aug 15. Erratum in: Clin Cancer Res. 2012 Mar 1;18(5):1484.

31.

Gβγ subunits inhibit Epac-induced melanoma cell migration.

Baljinnyam E, Umemura M, De Lorenzo MS, Xie LH, Nowycky M, Iwatsubo M, Chen S, Goydos JS, Iwatsubo K.

BMC Cancer. 2011 Jun 17;11:256. doi: 10.1186/1471-2407-11-256.

32.

Epac1 promotes melanoma metastasis via modification of heparan sulfate.

Baljinnyam E, Umemura M, De Lorenzo MS, Iwatsubo M, Chen S, Goydos JS, Iwatsubo K.

Pigment Cell Melanoma Res. 2011 Aug;24(4):680-7. doi: 10.1111/j.1755-148X.2011.00863.x. Epub 2011 May 13.

PMID:
21539721
33.

Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition.

Cohen-Solal KA, Merrigan KT, Chan JL, Goydos JS, Chen W, Foran DJ, Liu F, Lasfar A, Reiss M.

Pigment Cell Melanoma Res. 2011 Jun;24(3):512-24. doi: 10.1111/j.1755-148X.2011.00858.x. Epub 2011 Apr 28.

34.

Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.

Lee JH, Chen Y, Chan JL, Qian YW, Goydos JS.

Cancer Immunol Immunother. 2011 May;60(5):685-92. doi: 10.1007/s00262-011-0982-x. Epub 2011 Feb 16.

PMID:
21327637
35.

Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo.

Khan AJ, Wall B, Ahlawat S, Green C, Schiff D, Mehnert JM, Goydos JS, Chen S, Haffty BG.

Clin Cancer Res. 2011 Apr 1;17(7):1807-14. doi: 10.1158/1078-0432.CCR-10-1276. Epub 2011 Feb 15.

36.

Surveillance after surgical treatment of melanoma: futility of routine chest radiography.

Brown RE, Stromberg AJ, Hagendoorn LJ, Hulsewede DY, Ross MI, Noyes RD, Goydos JS, Urist MM, Edwards MJ, Scoggins CR, McMasters KM, Martin RC 2nd.

Surgery. 2010 Oct;148(4):711-6; discussion 716-7. doi: 10.1016/j.surg.2010.07.042. Epub 2010 Aug 30.

PMID:
20800862
37.

GLI2-mediated melanoma invasion and metastasis.

Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, Luciani F, Hoek KS, Juàrez P, Goydos JS, Fournier PJ, Sibon C, Bertolotto C, Verrecchia F, Saule S, Delmas V, Ballotti R, Larue L, Saiag P, Guise TA, Mauviel A.

J Natl Cancer Inst. 2010 Aug 4;102(15):1148-59. doi: 10.1093/jnci/djq257. Epub 2010 Jul 21.

38.

The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.

Yang NY, Lopez-Bergami P, Goydos JS, Yip D, Walker AM, Pasquale EB, Ethell IM.

Pigment Cell Melanoma Res. 2010 Oct;23(5):684-7. doi: 10.1111/j.1755-148X.2010.00745.x. Epub 2010 Jul 23. No abstract available.

39.

Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism.

Baljinnyam E, De Lorenzo MS, Xie LH, Iwatsubo M, Chen S, Goydos JS, Nowycky MC, Iwatsubo K.

Cancer Res. 2010 Jul 1;70(13):5607-17. doi: 10.1158/0008-5472.CAN-10-0056. Epub 2010 Jun 15.

40.

The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.

Le MN, Chan JL, Rosenberg SA, Nabatian AS, Merrigan KT, Cohen-Solal KA, Goydos JS.

J Invest Dermatol. 2010 Sep;130(9):2240-9. doi: 10.1038/jid.2010.126. Epub 2010 May 27.

41.

Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.

Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Dirk Noyes R, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM.

Ann Surg Oncol. 2010 Mar;17(3):709-17. doi: 10.1245/s10434-009-0858-x. Epub 2009 Dec 5.

PMID:
19967459
42.

AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).

Shin SS, Wall BA, Goydos JS, Chen S.

Pigment Cell Melanoma Res. 2010 Feb;23(1):103-11. doi: 10.1111/j.1755-148X.2009.00648.x. Epub 2009 Oct 20.

43.

A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma.

Yip D, Le MN, Chan JL, Lee JH, Mehnert JA, Yudd A, Kempf J, Shih WJ, Chen S, Goydos JS.

Clin Cancer Res. 2009 Jun 1;15(11):3896-902. doi: 10.1158/1078-0432.CCR-08-3303. Epub 2009 May 19.

44.

Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.

Solit DB, Osman I, Polsky D, Panageas KS, Daud A, Goydos JS, Teitcher J, Wolchok JD, Germino FJ, Krown SE, Coit D, Rosen N, Chapman PB.

Clin Cancer Res. 2008 Dec 15;14(24):8302-7. doi: 10.1158/1078-0432.CCR-08-1002.

45.

The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways.

Qi J, Nakayama K, Gaitonde S, Goydos JS, Krajewski S, Eroshkin A, Bar-Sagi D, Bowtell D, Ronai Z.

Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16713-8. doi: 10.1073/pnas.0804063105. Epub 2008 Oct 22.

46.

Effect of multiple-nodal basin drainage on cutaneous melanoma.

Federico AC, Chagpar AB, Ross MI, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, McMasters KM, Scoggins CR; Sunbelt Melanoma Trial.

Arch Surg. 2008 Jul;143(7):632-7; discussion 637-8. doi: 10.1001/archsurg.143.7.632.

PMID:
18645103
47.

Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.

Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC 2nd, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM.

J Surg Res. 2007 Nov;143(1):164-8.

PMID:
17950088
48.

Rewired ERK-JNK signaling pathways in melanoma.

Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z.

Cancer Cell. 2007 May;11(5):447-60.

49.

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.

Namkoong J, Shin SS, Lee HJ, Marín YE, Wall BA, Goydos JS, Chen S.

Cancer Res. 2007 Mar 1;67(5):2298-305.

50.

Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.

Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, Edwards MJ, Martin RC, Lewis AM, Stromberg AJ, Conrad AJ, Hagendoorn L, Albrecht J, McMasters KM.

J Clin Oncol. 2006 Jun 20;24(18):2849-57.

PMID:
16782924

Supplemental Content

Loading ...
Support Center